v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net income $ 115,602 $ 81,652
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 18,213 17,240
Non-cash interest income, net (1,533) (3,661)
Non-cash change in investments 476 1,247
Change in deferred revenue (38,750) (27,542)
Deferred income taxes 10,651 11,789
Share-based compensation 9,498 9,386
(Increase) Decrease in assets:    
Receivables (115,966) (28,337)
Deferred charges and other assets (2,201) (27,577)
(Decrease) Increase in liabilities:    
Accounts payable 1,730 3,522
Accrued compensation and other expenses (17,709) 13,054
Net cash (used in) provided by operating activities (19,989) 50,773
Cash flows from investing activities:    
Purchases of short-term investments (86,864) (167,086)
Sales of short-term investments 173,029 191,702
Purchases of property and equipment (14,508) (444)
Capitalized patent costs (12,149) (8,973)
Long-term investments 0 1,576
Net cash provided by investing activities 59,508 16,775
Cash flows from financing activities:    
Payments on long-term debt (1,284) (1,590)
Repurchase of common stock (5,249) (28,868)
Net proceeds from exercise of stock options 7,316 0
Taxes withheld upon restricted stock unit vestings (32,177) (8,635)
Dividends paid (11,557) (10,226)
Net cash used in financing activities (42,951) (49,319)
Net (decrease) increase in cash, cash equivalents and restricted cash (3,432) 18,229
Cash, cash equivalents and restricted cash, beginning of period 551,547 442,961
Cash, cash equivalents and restricted cash, end of period $ 548,115 $ 461,190